Chemotherapy Market 2027 by Indication, Drug Class, Route of Administration, End User | The Insight Partners

Chemotherapy Market to 2027 - Global Analysis and Forecasts by Indication ( Colorectal Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Ovarian Cancer, Lymphoma, Prostate Cancer, Leukemia, others ); Drug Class ( Topoisomerase Inhibitors, Mitotic inhibitors, Antitumor antibiotic, Alkylating agents, others ); Route of Administration ( Subcutaneous, Intra-Muscular, Intravenous, Intravesicular, Intraventricular/Intrathecal, Topical, Oral, Intraperitoneal, others ); End User ( Hospitals and Clinics, Specialty Centers, others )

Report Code: TIPRE00007601 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Chemotherapy is a cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. In chemotherapy, a chemical drug is used to stop the growth of the cancer cell. Chemotherapy affects the rapid growth of the cancerous cell. It is used for various types of cancer treatment.

MARKET DYNAMICS

The substantial success rate received by chemotherapy procedures is higher than other treatment methods available presently, which is a crucial factor motivating the market. Moreover, the lucrative nature of the chemotherapy market and the growth potential forecasted for the market have influenced the entry of major pharmaceutical companies along with independent investors into the market, thus reinforcing the development of the market. Also, the market is expected to be substantially motivated by increased government initiatives towards the development of the market. The research and development being conducted are expected to open up new opportunities for expansion in the approaching period.

MARKET SCOPE

The "Chemotherapy Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of in chemotherapy market with detailed market segmentation by indication, drug class, route of administration, end user and geography. The chemotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in chemotherapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The chemotherapy market is segmented on the basis of indication, drug class, route of administration and by end user. Based on indication the market is segmented as colorectal cancer, breast cancer, lung cancer, stomach cancer, ovarian cancer, lymphoma, prostate cancer, leukemia and others. On the basis of drug class the market is categorized as Topoisomerase Inhibitors, Mitotic inhibitors, Antitumor antibiotic, Alkylating agents and others. On the basis of route of administration the market is categorized as subcutaneous, intra-muscular, intravenous, intravesicular, intraventricular/intrathecal, oral, intraperitoneal, topical and others. On the basis of end user the market is categorized as hospitals, Specialty Centers and others.



Get more information on this report :

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in chemotherapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chemotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting chemotherapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chemotherapy market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the in chemotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in chemotherapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for in chemotherapy market in the global market. Below mentioned is the list of few companies engaged in the Chemotherapy market.

The report also includes the profiles of key in chemotherapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Bristol-Myers Squibb Company
  •  Celgene Corporation
  •  Eli Lilly and Company
  •  F. Hoffmann-La Roche Ltd
  •  GlaxoSmithKline PLC
  •  Johnson & Johnson Services Inc
  •  Merck & Co. Inc.
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi S.A.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chemotherapy Market - By Indication
1.3.2 Chemotherapy Market - By Drug Class
1.3.3 Chemotherapy Market - By Route of Administration
1.3.4 Chemotherapy Market - By End User
1.3.5 Chemotherapy Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHEMOTHERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHEMOTHERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHEMOTHERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CHEMOTHERAPY - GLOBAL MARKET OVERVIEW
6.2. CHEMOTHERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CHEMOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. COLORECTAL CANCER
7.3.1. Overview
7.3.2. Colorectal Cancer Market Forecast and Analysis
7.4. BREAST CANCER
7.4.1. Overview
7.4.2. Breast Cancer Market Forecast and Analysis
7.5. LUNG CANCER
7.5.1. Overview
7.5.2. Lung Cancer Market Forecast and Analysis
7.6. STOMACH CANCER
7.6.1. Overview
7.6.2. Stomach Cancer Market Forecast and Analysis
7.7. OVARIAN CANCER
7.7.1. Overview
7.7.2. Ovarian Cancer Market Forecast and Analysis
7.8. LYMPHOMA
7.8.1. Overview
7.8.2. Lymphoma Market Forecast and Analysis
7.9. PROSTATE CANCER
7.9.1. Overview
7.9.2. Prostate Cancer Market Forecast and Analysis
7.10. LEUKEMIA
7.10.1. Overview
7.10.2. Leukemia Market Forecast and Analysis
7.11. OTHERS
7.11.1. Overview
7.11.2. others Market Forecast and Analysis
8. CHEMOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. TOPOISOMERASE INHIBITORS
8.3.1. Overview
8.3.2. Topoisomerase Inhibitors Market Forecast and Analysis
8.4. MITOTIC INHIBITORS
8.4.1. Overview
8.4.2. Mitotic inhibitors Market Forecast and Analysis
8.5. ANTITUMOR ANTIBIOTIC
8.5.1. Overview
8.5.2. Antitumor antibiotic Market Forecast and Analysis
8.6. ALKYLATING AGENTS
8.6.1. Overview
8.6.2. Alkylating agents Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. others Market Forecast and Analysis
9. CHEMOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. SUBCUTANEOUS
9.3.1. Overview
9.3.2. Subcutaneous Market Forecast and Analysis
9.4. INTRA-MUSCULAR
9.4.1. Overview
9.4.2. Intra-Muscular Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. INTRAVESICULAR
9.6.1. Overview
9.6.2. Intravesicular Market Forecast and Analysis
9.7. INTRAVENTRICULAR/INTRATHECAL
9.7.1. Overview
9.7.2. Intraventricular/Intrathecal Market Forecast and Analysis
9.8. TOPICAL
9.8.1. Overview
9.8.2. Topical Market Forecast and Analysis
9.9. ORAL
9.9.1. Overview
9.9.2. Oral Market Forecast and Analysis
9.10. INTRAPERITONEAL
9.10.1. Overview
9.10.2. Intraperitoneal Market Forecast and Analysis
9.11. OTHERS
9.11.1. Overview
9.11.2. others Market Forecast and Analysis
10. CHEMOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. SPECIALTY CENTERS
10.4.1. Overview
10.4.2. Specialty Centers Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. others Market Forecast and Analysis
11. CHEMOTHERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Chemotherapy Market Overview
11.1.2 North America Chemotherapy Market Forecasts and Analysis
11.1.3 North America Chemotherapy Market Forecasts and Analysis - By Indication
11.1.4 North America Chemotherapy Market Forecasts and Analysis - By Drug Class
11.1.5 North America Chemotherapy Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Chemotherapy Market Forecasts and Analysis - By End User
11.1.7 North America Chemotherapy Market Forecasts and Analysis - By Countries
11.1.7.1 United States Chemotherapy Market
11.1.7.1.1 United States Chemotherapy Market by Indication
11.1.7.1.2 United States Chemotherapy Market by Drug Class
11.1.7.1.3 United States Chemotherapy Market by Route of Administration
11.1.7.1.4 United States Chemotherapy Market by End User
11.1.7.2 Canada Chemotherapy Market
11.1.7.2.1 Canada Chemotherapy Market by Indication
11.1.7.2.2 Canada Chemotherapy Market by Drug Class
11.1.7.2.3 Canada Chemotherapy Market by Route of Administration
11.1.7.2.4 Canada Chemotherapy Market by End User
11.1.7.3 Mexico Chemotherapy Market
11.1.7.3.1 Mexico Chemotherapy Market by Indication
11.1.7.3.2 Mexico Chemotherapy Market by Drug Class
11.1.7.3.3 Mexico Chemotherapy Market by Route of Administration
11.1.7.3.4 Mexico Chemotherapy Market by End User
11.2. EUROPE
11.2.1 Europe Chemotherapy Market Overview
11.2.2 Europe Chemotherapy Market Forecasts and Analysis
11.2.3 Europe Chemotherapy Market Forecasts and Analysis - By Indication
11.2.4 Europe Chemotherapy Market Forecasts and Analysis - By Drug Class
11.2.5 Europe Chemotherapy Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Chemotherapy Market Forecasts and Analysis - By End User
11.2.7 Europe Chemotherapy Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Chemotherapy Market
11.2.7.1.1 Germany Chemotherapy Market by Indication
11.2.7.1.2 Germany Chemotherapy Market by Drug Class
11.2.7.1.3 Germany Chemotherapy Market by Route of Administration
11.2.7.1.4 Germany Chemotherapy Market by End User
11.2.7.2 France Chemotherapy Market
11.2.7.2.1 France Chemotherapy Market by Indication
11.2.7.2.2 France Chemotherapy Market by Drug Class
11.2.7.2.3 France Chemotherapy Market by Route of Administration
11.2.7.2.4 France Chemotherapy Market by End User
11.2.7.3 Italy Chemotherapy Market
11.2.7.3.1 Italy Chemotherapy Market by Indication
11.2.7.3.2 Italy Chemotherapy Market by Drug Class
11.2.7.3.3 Italy Chemotherapy Market by Route of Administration
11.2.7.3.4 Italy Chemotherapy Market by End User
11.2.7.4 Spain Chemotherapy Market
11.2.7.4.1 Spain Chemotherapy Market by Indication
11.2.7.4.2 Spain Chemotherapy Market by Drug Class
11.2.7.4.3 Spain Chemotherapy Market by Route of Administration
11.2.7.4.4 Spain Chemotherapy Market by End User
11.2.7.5 United Kingdom Chemotherapy Market
11.2.7.5.1 United Kingdom Chemotherapy Market by Indication
11.2.7.5.2 United Kingdom Chemotherapy Market by Drug Class
11.2.7.5.3 United Kingdom Chemotherapy Market by Route of Administration
11.2.7.5.4 United Kingdom Chemotherapy Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Chemotherapy Market Overview
11.3.2 Asia-Pacific Chemotherapy Market Forecasts and Analysis
11.3.3 Asia-Pacific Chemotherapy Market Forecasts and Analysis - By Indication
11.3.4 Asia-Pacific Chemotherapy Market Forecasts and Analysis - By Drug Class
11.3.5 Asia-Pacific Chemotherapy Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Chemotherapy Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Chemotherapy Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Chemotherapy Market
11.3.7.1.1 Australia Chemotherapy Market by Indication
11.3.7.1.2 Australia Chemotherapy Market by Drug Class
11.3.7.1.3 Australia Chemotherapy Market by Route of Administration
11.3.7.1.4 Australia Chemotherapy Market by End User
11.3.7.2 China Chemotherapy Market
11.3.7.2.1 China Chemotherapy Market by Indication
11.3.7.2.2 China Chemotherapy Market by Drug Class
11.3.7.2.3 China Chemotherapy Market by Route of Administration
11.3.7.2.4 China Chemotherapy Market by End User
11.3.7.3 India Chemotherapy Market
11.3.7.3.1 India Chemotherapy Market by Indication
11.3.7.3.2 India Chemotherapy Market by Drug Class
11.3.7.3.3 India Chemotherapy Market by Route of Administration
11.3.7.3.4 India Chemotherapy Market by End User
11.3.7.4 Japan Chemotherapy Market
11.3.7.4.1 Japan Chemotherapy Market by Indication
11.3.7.4.2 Japan Chemotherapy Market by Drug Class
11.3.7.4.3 Japan Chemotherapy Market by Route of Administration
11.3.7.4.4 Japan Chemotherapy Market by End User
11.3.7.5 South Korea Chemotherapy Market
11.3.7.5.1 South Korea Chemotherapy Market by Indication
11.3.7.5.2 South Korea Chemotherapy Market by Drug Class
11.3.7.5.3 South Korea Chemotherapy Market by Route of Administration
11.3.7.5.4 South Korea Chemotherapy Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Chemotherapy Market Overview
11.4.2 Middle East and Africa Chemotherapy Market Forecasts and Analysis
11.4.3 Middle East and Africa Chemotherapy Market Forecasts and Analysis - By Indication
11.4.4 Middle East and Africa Chemotherapy Market Forecasts and Analysis - By Drug Class
11.4.5 Middle East and Africa Chemotherapy Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Chemotherapy Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Chemotherapy Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Chemotherapy Market
11.4.7.1.1 South Africa Chemotherapy Market by Indication
11.4.7.1.2 South Africa Chemotherapy Market by Drug Class
11.4.7.1.3 South Africa Chemotherapy Market by Route of Administration
11.4.7.1.4 South Africa Chemotherapy Market by End User
11.4.7.2 Saudi Arabia Chemotherapy Market
11.4.7.2.1 Saudi Arabia Chemotherapy Market by Indication
11.4.7.2.2 Saudi Arabia Chemotherapy Market by Drug Class
11.4.7.2.3 Saudi Arabia Chemotherapy Market by Route of Administration
11.4.7.2.4 Saudi Arabia Chemotherapy Market by End User
11.4.7.3 U.A.E Chemotherapy Market
11.4.7.3.1 U.A.E Chemotherapy Market by Indication
11.4.7.3.2 U.A.E Chemotherapy Market by Drug Class
11.4.7.3.3 U.A.E Chemotherapy Market by Route of Administration
11.4.7.3.4 U.A.E Chemotherapy Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Chemotherapy Market Overview
11.5.2 South and Central America Chemotherapy Market Forecasts and Analysis
11.5.3 South and Central America Chemotherapy Market Forecasts and Analysis - By Indication
11.5.4 South and Central America Chemotherapy Market Forecasts and Analysis - By Drug Class
11.5.5 South and Central America Chemotherapy Market Forecasts and Analysis - By Route of Administration
11.5.6 South and Central America Chemotherapy Market Forecasts and Analysis - By End User
11.5.7 South and Central America Chemotherapy Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Chemotherapy Market
11.5.7.1.1 Brazil Chemotherapy Market by Indication
11.5.7.1.2 Brazil Chemotherapy Market by Drug Class
11.5.7.1.3 Brazil Chemotherapy Market by Route of Administration
11.5.7.1.4 Brazil Chemotherapy Market by End User
11.5.7.2 Argentina Chemotherapy Market
11.5.7.2.1 Argentina Chemotherapy Market by Indication
11.5.7.2.2 Argentina Chemotherapy Market by Drug Class
11.5.7.2.3 Argentina Chemotherapy Market by Route of Administration
11.5.7.2.4 Argentina Chemotherapy Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CHEMOTHERAPY MARKET, KEY COMPANY PROFILES
13.1. BRISTOL-MYERS SQUIBB COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CELGENE CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ELI LILLY AND COMPANY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMANN-LA ROCHE LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JOHNSON AND JOHNSON SERVICES INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK AND CO. INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NOVARTIS AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SANOFI S.A.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol-Myers Squibb Company
2. Celgene Corporation
3. Eli Lilly and Company
4. F. Hoffmann-La Roche Ltd
5. GlaxoSmithKline PLC
6. Johnson & Johnson Services Inc
7. Merck & Co. Inc.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi S.A.
TIPRE00007601
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Tags Chemotherapy Market Chemotherapy Market Research Chemotherapy Market Insight Chemotherapy Market Trends Chemotherapy Market Forecast Chemotherapy Market Share Chemotherapy Market 2027 Chemotherapy Market Growth Chemotherapy Industry Sector Chemotherapy PDF Report Chemotherapy Analysis Ch